ELAC2 anticorps (AA 1-270)
-
- Antigène Voir toutes ELAC2 Anticorps
- ELAC2 (ElaC Homolog 2 (ELAC2))
-
Épitope
- AA 1-270
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ELAC2 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Séquence
- MWALCSLLRS AAGRTMSQGR TISQAPARRE RPRKDPLRHL RTREKRGPSG CSGGPNTVYL QVVAAGSRDS GAALYVFSEF NRYLFNCGEG VQRLMQEHKL KVARLDNIFL TRMHWSNVGG LSGMILTLKE TGLPKCVLSG PPQLEKYLEA IKIFSGPLKG IELAVRPHSA PEYEDETMTV YQIPIHSEQR RGKHQPWQSP ERPLSRLSPE RSSDSESNEN EPHLPHGVSQ RRGVRDSSLV VAFICKLHLK RGNFLVLKAK EMGLPVGTAA
- Réactivité croisée
- Humain, Souris, Rat
- Attributs du produit
- Polyclonal Antibodies
- Purification
- Affinity purification
- Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-270 of human ELAC2 (NP_776065.1).
- Isotype
- IgG
- Top Product
- Discover our top product ELAC2 Anticorps primaire
-
-
- Indications d'application
- WB,1:500 - 1:2000,IHC,1:50 - 1:200
- Commentaires
-
HIGH QUALITY
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- ELAC2 (ElaC Homolog 2 (ELAC2))
- Autre désignation
- ELAC2 (ELAC2 Produits)
- Synonymes
- anticorps 1110017O07Rik, anticorps D11Wsu80e, anticorps Hpc2, anticorps ELC2, anticorps HPC2, anticorps elaC ribonuclease Z 2, anticorps ELAC2, anticorps Elac2
- Sujet
- The protein encoded by this gene has a C-terminal domain with tRNA 3' processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.,ELAC2,COXPD17,ELC2,HPC2,Epigenetics & Nuclear Signaling,RNA Binding,Cancer,Cell Biology & Developmental Biology,Cell Cycle,Cell cycle inhibitors,ELAC2
- Poids moléculaire
- 50 kDa/56 kDa/87 kDa/92 kDa
- ID gène
- 60528
- UniProt
- Q9BQ52
-